Decreased cardiac mortality with nicorandil in patients with ischemic heart failure - Wikidata - wikimedia - TriplyDB

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

http://www.wikidata.org/entity/Q33749769

about

Myocardial Protective Effects of Nicorandil on Rats with Type 2 Diabetic Cardiomyopathy

P2860

Q58796478-EB17B557-FF52-4CC1-AEA5-59D939498DE1

P2860

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

http://www.wikidata.org/entity/Q33749769

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

@ast

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

@en

type

label

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

@ast

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

@en

prefLabel

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

@ast

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

@en

P1433

Q33749769-3E3F5C05-2F29-40B4-9F7B-25E8C6FEDC8F

P1476

Q33749769-877144C3-1309-42C1-A2E8-2D481DCF9772

P2093

Q33749769-07562F4B-6D8B-4BEE-9143-346743C0F707

Q33749769-0CB6131C-57E8-4351-93B3-4F3E854EF308

Q33749769-1046EDA0-DCCE-4F72-AF5E-E9344A57CE3D

Q33749769-5972D6E5-D231-4737-8F79-C1232E3C4E8C

Q33749769-921256FD-4F0D-4A04-907C-3CCB1CDBB8D4

Q33749769-DA213078-53EC-40CC-AECA-773ADF4D27CA

Q33749769-EB8E3FD8-ACE6-4298-916A-BB57CDC431F4

Q33749769-F45CF6BF-B581-40F8-B34A-A29275C216B1

P2860

Q33749769-09B7CDFB-633F-4487-98BB-5A09D559C37C

Q33749769-0F80846B-DE5B-475C-A47F-10D8BC328491

Q33749769-2185F8F0-1B38-4FD2-9A2F-875B3A6D9879

Q33749769-4A4DDFAC-C74D-477A-B2AB-82FB1B42DD2E

Q33749769-4C4F8888-F4D9-464E-A2B2-2127DC44F1C9

Q33749769-74EDCC1B-46B3-4B62-B329-2C2594E562DE

Q33749769-8C1A1DD1-928A-48FA-956B-BF6D353EF710

Q33749769-9A884A74-FEE4-4871-A628-C84D432F90E2

Q33749769-9BFD274F-EC21-41BC-B60A-237C74FBCE55

Q33749769-AF5735C0-6C50-411F-98A5-3FAE007E174C

P2888

Q33749769-059AB640-037B-423C-B470-55EE3F02EB0D

P304

Q33749769-0148CE7A-78C3-4381-A1BE-46060BCE4E58

P31

Q33749769-2A887E49-DAB3-47C6-A27B-FE24C71A6B3B

P356

Q33749769-DF26BDE0-27F7-4A9C-8D58-729279508E1D

P433

Q33749769-2E9E6289-8F13-450C-8AFF-5CFA2F6EF27F

P478

Q33749769-8B0AB631-8C72-4405-AC3A-0240BB15E337

P50

Q33749769-9A43423B-C392-46D9-B688-3B1D1576F37D

P577

Q33749769-E895B3A9-2981-444F-BE0A-8BCB067377EB

P6179

Q33749769-A1B5D95D-DC3B-419A-82B2-9389EE07A46E

P698

Q33749769-D3FA6AA9-AD22-4754-BDE2-2E1D67DC370A

P932

Q33749769-AD6A07D0-B3E2-4829-BB55-932DE36CE775

P356

S12872-017-0577-3

P1433

BMC Cardiovascular Disorders

P1476

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

@en

P2093

Atsushi Kobayashi

http://www.w3.org/2001/XMLSchema#string

Masayoshi Oikawa

http://www.w3.org/2001/XMLSchema#string

Satoshi Suzuki

http://www.w3.org/2001/XMLSchema#string

Shunsuke Watanabe

http://www.w3.org/2001/XMLSchema#string

Takamasa Sato

http://www.w3.org/2001/XMLSchema#string

Tetsuro Yokokawa

http://www.w3.org/2001/XMLSchema#string

Yasuchika Takeishi

http://www.w3.org/2001/XMLSchema#string

Yu Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Surgical treatment of moderate ischemic mitral regurgitation.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

The natural history of congestive heart failure: the Framingham study.

Coronary-artery bypass surgery in patients with left ventricular dysfunction

Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF

Worldwide risk factors for heart failure: a systematic review and pooled analysis.

Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial

All-cause mortality and cardiovascular events with nicorandil in patients with IHD: systematic review and meta-analysis of the literature.

P2888

s12872-017-0577-3

P304

141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12872-017-0577-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Akiomi Yoshihisa

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085705063

http://www.w3.org/2001/XMLSchema#string

P698

28569214

http://www.w3.org/2001/XMLSchema#string

P932

5452293

http://www.w3.org/2001/XMLSchema#string